Request for Information – Prophylactic Platform for Medical Countermeasures
- Client
- Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND)
- Solicitation No.
- W911SR-26-S-PPFC
- Posted
- 10/19/2026
- Category
- US Federal
- Budget
- —
- NAICS
- 541715
- Set-aside
- No Set aside used
- Contact
- Scott Hoffman
Description
AI GeneratedThe Chemical, Biological, Radiological, Nuclear Medical - Accelerated Defense Pharmaceuticals program seeks information regarding advanced prophylactic platform technologies directed against specific chemical, biological, radiological, and nuclear threats. The buyer needs information on the design, manufacturing, non-clinical testing, and clinical testing of candidates to progress existing platforms toward Phase I or Phase II clinical trials regulatory and operational milestones. Qualified commercial and academic product developers are eligible to submit responses. Interested parties must email their submissions as a single searchable PDF document of up to four pages in total, adhering to strict margin and font guidelines. Respondents must include corporate experience, indicative high-level timelines, and high-level Rough Order of Magnitude budgetary cost bands.
Key solicitation details
AI-extracted from RFI Prophylactic Platform Technologies for Medical Countermeasures_19Oct2026.pdf, Appendix 2_Draft_Description_Statement_of_Objectives_19Oct2026.pdf. Confirm against the original documents before bidding.
This Request for Information seeks input from qualified commercial and academic product developers regarding advanced prophylactic platform technologies directed against specific CBRN threats. The goal is to accelerate innovation and progress existing candidate platforms toward Phase I or Phase II clinical trial milestones. Qualified commercial and academic product developers with mature or proven platform technologies are eligible to respond.
- Issued by
- Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND)
- How to submit
- Electronic via email
- Submission details
- Submit a single searchable PDF document to the Government Points of Contact with subject line 'RFI Response: PME CBRND JPM CBRN Medical ADP - [Organization Name]'. Core capability description limited to 4 pages (12-point font, 1-inch margins), plus an optional 1-page cover page.
- Contract term
- up to four (4) years from date of award
- Place of performance
- Primary place of performance will be the contractors' facilities
How proposals are evaluated
| Performer Past FDA Experience | |
| Performer Past Experience |
Scope of work
- Design, manufacture, non-clinical, and clinical testing of prophylactic platform technology for CBRN threats
- Formulate final prototype candidate products for clinical evaluation
- Manufacture and release cGMP prototype products for clinical trial use
- Regulatory interactions and filing of Investigational New Drug (IND) applications
- Generation of Regulatory Strategy and Target Product Profile documents
- Delivery of monthly technical and financial reports, spend plans, and progress schedules
- Draft and final non-clinical and clinical study reports
Minimum qualifications
- Demonstrated, successful history of designing, manufacturing, and clinical testing of prophylactic MCM platforms
Documents to include with the bid
- Cover page
- Prophylactic Platform Technology Capability Description
Official SAM.gov notice
- Solicitation number
- W911SR27SPPFC
- Agency
- Department of Defense
- Buying office
- Dept of the Army › W6QK ACC-APG
- Notice type
- Special Notice
- Responses due
- Nov 18, 2026, 4:30 PM ET
- Posted on SAM.gov
- Oct 19, 2026
- NAICS
- 541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product/service code
- AC15
- Set-aside
- No Set aside used
- Place of performance
- Frederick, MD, 21702
- Contracting contact
- Scott Hoffman
scott.i.hoffman2.civ@army.mil - Additional contact
- Alexander Mayatte
alexander.z.mayatte.civ@army.mil
Read the official notice description
The Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), Medical - Accelerated Defense Pharmaceuticals program is formally requesting information from capable companies. The objective of the program is to progress the development of existing prophylactic MCMs manufactured on existing platform technologies that support clinical safety and/or possess strong preclinical immunogenicity, safety, and efficacy data.
Source: SAM.gov contract opportunities data (U.S. federal public data).
Incumbent
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). This is not this requirement's award history.
Recent similar awards: Department of Defense, NAICS 541715, performed in MD
| Vendor and award | Value | Ends |
|---|---|---|
| NORTHROP GRUMMAN SYSTEMS CORPORATIONFA237726CB034 · COMBAT IDENTIFICATION AUTOMATED TARGET RECOGNITION TECHNOLOGIES (CATCH) CALL 06 | $1.0M | Oct 17, 2031 |
| APPLIED RESEARCH ASSOCIATES, INC.W911QX26CA007 · ENGINEERING AND ANALYSIS SUPPORT FOR THE DEVELOPMENT OF THE ADVANCED JOINT EFFECTIVENESS M | $478.6K | Sep 1, 2031 |
| THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLCFA865626FB009 · AIR WARFARE SYSTEMS | $1.5M | Jul 31, 2031 |
| THE SURVICE ENGINEERING COMPANY LLCW911QX26FA026 · ARMY RESEARCH, TECHNICAL AND ENGINEERING SERVICES (ARTES) | $10.9M | Jun 30, 2031 |
| CARDINAL ENGINEERING, LLCN0001425C1303 · PERFORM INVESTIGATION, DEVELOPMENT, AND DEMONSTRATION OF POWER AND ENERGY FOCUS AREA SOLUT | $4.1M | Jun 15, 2031 |
Top vendors in this category: Department of Defense, NAICS 541715, since Oct 1, 2024
22,948 contract awards in this NAICS over the period.
- 1. LOCKHEED MARTIN CORPORATION$5.3B
- 2. FLUOR MARINE PROPULSION, LLC$4.2B
- 3. LOCKHEED MARTIN CORP$3.8B
- 4. THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLC$3.0B
- 5. THE AEROSPACE CORPORATION$2.2B
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.
Verify important details
Document checkConfirm submission instructions and amendments with the issuing agency before responding.
Personalized fit score
Sign up free to see how well this opportunity fits your company — based on your saved profile.
Sign up to see your fit score